120 related articles for article (PubMed ID: 16804901)
1. Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women.
Ma H; Jin G; Hu Z; Zhai X; Chen W; Wang S; Wang X; Qin J; Gao J; Liu J; Wang X; Wei Q; Shen H
Int J Cancer; 2006 Nov; 119(9):2173-8. PubMed ID: 16804901
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants of p21 and p27 and hepatocellular cancer risk in a Chinese Han population: a case-control study.
Liu F; Wei YG; Luo LM; Wang WT; Yan LN; Wen TF; Xu MQ; Yang JY; Li B
Int J Cancer; 2013 May; 132(9):2056-64. PubMed ID: 23034899
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study.
Chen J; Amos CI; Merriman KW; Wei Q; Sen S; Killary AM; Frazier ML
Pancreas; 2010 Jan; 39(1):1-4. PubMed ID: 19910837
[TBL] [Abstract][Full Text] [Related]
4. [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Guo W; Cui YJ; Fang SM; Li Y; Wang N; Zhang JH
Ai Zheng; 2006 Feb; 25(2):194-9. PubMed ID: 16480585
[TBL] [Abstract][Full Text] [Related]
5. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.
Kibel AS; Suarez BK; Belani J; Oh J; Webster R; Brophy-Ebbers M; Guo C; Catalona WJ; Picus J; Goodfellow PJ
Cancer Res; 2003 May; 63(9):2033-6. PubMed ID: 12727815
[TBL] [Abstract][Full Text] [Related]
6. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW
Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of CDKN1A or both CDKN1A and CDKN1B affects the pubertal development of mouse Leydig cells.
Lin H; Huang Y; Su Z; Zhu Q; Ge Y; Wang G; Wang CQ; Mukai M; Holsberger DR; Cooke PS; Lian QQ; Ge RS
Biol Reprod; 2015 Mar; 92(3):77. PubMed ID: 25609837
[TBL] [Abstract][Full Text] [Related]
8. Association between CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis.
Cacina C; Yaylim-Eraltan I; Arikan S; Saglam EK; Zeybek U; Isbir T
In Vivo; 2010; 24(2):179-83. PubMed ID: 20363991
[TBL] [Abstract][Full Text] [Related]
9. [Effects of transfected pIRES-p21(waf1)-p27(kip1) gene on the duplication of centrosomes and the proliferation of breast cancer cell line MCF-7].
Jiang DD; Li FN; Liu XP
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(46):3295-8. PubMed ID: 20193371
[TBL] [Abstract][Full Text] [Related]
10. CCND1 and CDKN1B polymorphisms and risk of breast cancer.
Canbay E; Eraltan IY; Cercel A; Isbir T; Gazioglu E; Aydogan F; Cacina C; Cengiz A; Ferahman M; Zengin E; Unal H
Anticancer Res; 2010 Jul; 30(7):3093-8. PubMed ID: 20683061
[TBL] [Abstract][Full Text] [Related]
11. Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population.
Ma H; Hu Z; Zhai X; Wang S; Wang X; Qin J; Chen W; Jin G; Liu J; Gao J; Wang X; Wei Q; Shen H
Carcinogenesis; 2006 Apr; 27(4):766-71. PubMed ID: 16314399
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression.
Lin JH; Morikawa T; Chan AT; Kuchiba A; Shima K; Nosho K; Kirkner G; Zhang SM; Manson JE; Giovannucci E; Fuchs CS; Ogino S
Cancer Res; 2012 Jun; 72(12):3020-8. PubMed ID: 22511578
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle dysregulation influences survival in high risk breast cancer patients.
Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q
Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
[TBL] [Abstract][Full Text] [Related]
16. Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro.
Jiang D; Wang X; Liu X; Li F
Breast Cancer; 2014 Sep; 21(5):614-23. PubMed ID: 23338153
[TBL] [Abstract][Full Text] [Related]
17. Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population.
Liu J; Zhai X; Jin G; Hu Z; Wang S; Wang X; Qin J; Gao J; Ma H; Wang X; Wei Q; Shen H
Int J Cancer; 2006 May; 118(10):2554-8. PubMed ID: 16358261
[TBL] [Abstract][Full Text] [Related]
18. Role of the CDKN1A/p21, CDKN1C/p57, and CDKN2A/p16 genes in the risk of atherosclerosis and myocardial infarction.
Rodríguez I; Coto E; Reguero JR; González P; Andrés V; Lozano I; Martín M; Alvarez V; Morís C
Cell Cycle; 2007 Mar; 6(5):620-5. PubMed ID: 17351341
[TBL] [Abstract][Full Text] [Related]
19. Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.
Landa I; Montero-Conde C; Malanga D; De Gisi S; Pita G; Leandro-García LJ; Inglada-Pérez L; Letón R; De Marco C; Rodríguez-Antona C; Viglietto G; Robledo M
Endocr Relat Cancer; 2010 Jun; 17(2):317-28. PubMed ID: 20075119
[TBL] [Abstract][Full Text] [Related]
20. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
Jin X; Kang S; Wang N; Xing YP; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
